OWL-1023

N/A

Report date: 2024/01/15 19:42:46

Base Information

Drug NameOWL-1023
Drug Alias NameOWL-1023
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBrain Injuries, Traumatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOwl Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesOwl Therapeutics
Inactive CompaniesN/A
Active IndicationsBrain Injuries, Traumatic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A